BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8963770)

  • 21. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
    Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic inhibition of the complement system.
    Makrides SC
    Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical considerations in clinical cardiac xenografting.
    Pierson RN; White DJ; Wallwork J
    J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complement inhibition: a new therapeutic modality?].
    Porcel JM
    Med Clin (Barc); 1995 Nov; 105(18):700-2. PubMed ID: 8538252
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recent knowledge of complement system and the protective roles].
    Mizuno M; Matsuo S
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():49-52. PubMed ID: 20941999
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of pigs transgenic for human regulators of complement activation.
    Yannoutsos N; Langford GA; Cozzi E; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1995 Feb; 27(1):324-5. PubMed ID: 7533399
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
    Gorter A; Meri S
    Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD46: expanding beyond complement regulation.
    Riley-Vargas RC; Gill DB; Kemper C; Liszewski MK; Atkinson JP
    Trends Immunol; 2004 Sep; 25(9):496-503. PubMed ID: 15324743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
    Murray KP; Mathure S; Kaul R; Khan S; Carson LF; Twiggs LB; Martens MG; Kaul A
    Gynecol Oncol; 2000 Feb; 76(2):176-82. PubMed ID: 10637067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
    Heckl-Ostreicher B; Kirschfink M
    Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
    Fearon DT
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complement regulatory proteins].
    Miyagawa S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
    [No Abstract]   [Full Text] [Related]  

  • 36. ''Homologous restriction'' in complement lysis: roles of membrane complement regulators.
    Morgan BP; Berg CW; Harris CL
    Xenotransplantation; 2005 Jul; 12(4):258-65. PubMed ID: 15943774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of human decay accelerating factor in transgenic pigs.
    Cozzi E; Langford GA; Richards A; Elsome K; Lancaster R; Chen P; Yannoutsos N; White DJ
    Transplant Proc; 1994 Jun; 26(3):1402-3. PubMed ID: 7518135
    [No Abstract]   [Full Text] [Related]  

  • 38. [Self- and non-self recognition mechanism via the complement system].
    Okada N
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
    [No Abstract]   [Full Text] [Related]  

  • 39. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function.
    Russell S
    Tissue Antigens; 2004 Aug; 64(2):111-8. PubMed ID: 15245366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.